Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
24.40
-0.65 (-2.59%)
At close: Feb 26, 2026, 4:00 PM EST
24.10
-0.30 (-1.23%)
After-hours: Feb 26, 2026, 4:10 PM EST

AAPG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,2381,8129958519321,096
Market Cap Growth
40.34%82.10%16.89%-8.64%-15.02%39.78%
Enterprise Value
2,2481,8961,0098307981,045
PS Ratio
41.0513.4831.7827.99212.05574.86
PB Ratio
23.7348.2399.8714.364.798.45
P/TBV Ratio
28.1280.87-19.595.159.47
EV/Sales Ratio
41.2214.1132.2427.31181.70548.17
Debt / Equity Ratio
2.546.0925.424.390.880.63
Net Debt / Equity Ratio
0.081.479.840.71-0.54-0.59
Net Debt / EBITDA Ratio
-0.05-1.34-0.85-0.340.730.75
Net Debt / FCF Ratio
-0.25-2.96-0.90-0.340.640.58
Asset Turnover
0.130.380.080.070.010.01
Inventory Turnover
3.702.562.383.29--
Quick Ratio
1.401.171.351.785.053.77
Current Ratio
1.541.261.441.865.223.91
Return on Equity (ROE)
-159.65%-235.32%-386.28%-107.45%-75.18%-78.02%
Return on Assets (ROA)
-22.77%-9.25%-20.92%-19.14%-24.97%-29.14%
Return on Capital Employed (ROCE)
-62.00%-26.10%-57.00%-45.30%-36.20%-47.00%
Earnings Yield
-7.23%-3.07%-13.12%-15.04%-13.22%-9.47%
FCF Yield
-1.42%-1.03%-10.95%-14.60%-17.57%-12.02%
Buyback Yield / Dilution
-12.40%-7.00%-7.07%-3.56%-17.93%-84.97%
Updated Sep 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q